Industries > Pharma > Global Pre-Filled Syringes Market Forecast 2017-2027

Global Pre-Filled Syringes Market Forecast 2017-2027

Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors

PUBLISHED: 31 March 2017
PAGES: 211
PRODUCT CODE: PHA0180
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
SKU: PHA0180 Categories: , Tags: ,

The global pre-filled syringes market is expected to grow at a moderate growth rate over the forecast period. The global pre-filled syringes market was valued at $4,663m in 2016. Visiongain forecasts this market to increase to $7,629m in 2021. The market will then continue to increase to $12,764m in 2027, growing at a CAGR of 9.7% between 2016 and 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 211-page report you will receive 68 tables and 55 figures – all unavailable elsewhere.

The 211-page report provides clear detailed insight into the global pre-filled syringes market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Pre-Filled Syringes Market Forecast 2017-2027

Report Scope
Global Pre-Filled Syringes market forecasts from 2017-2027

• Pre-Filled Syringes national market forecasts from 2017-2027, covering:
– United States
– Japan
– Germany
– France
– United Kingdom
– Italy
– Spain
– Brazil
– Russia
– India
– China

• Pre-Filled Syringes submarket forecasts from 2017-2027 covering:
Glass Pre-Filled Syringes
Pen Injectors and Autoinjectors
Plastic Pre-Filled Syringes

• Forecasts from 2017-2027 of the leading therapeutic sectors for the Pre-Filled Syringes market:
– Insulin Therapies
– Rheumatoid Arthritis (RA) Therapies
– Growth Hormones
– Vaccines
– PCSK9 Inhibitors

• Forecasts from 2017-2027 of the leading pre-filled devices:
– Lantus
– NovoRapid/Novolog
– Humalog
– Humira
– Enbrel
– Norditropin
– Genotropin
– Praluent
– Repatha

• Assessment of the leading pre-filled syringes manufacturers and related technology manufacturers

SWOT and STEP analysis

Visiongain’s study is intended for anyone requiring commercial analyses for the Pre-Filled Syringes Market and leading companies. You find data, trends and predictions.

Buy our report today Global Pre-Filled Syringes Market Forecast 2017-2027: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Pre-Filled Syringes Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Pre-Filled Syringes Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Dermatological Drugs Market Report 2021-2031

The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.

18 January 2021

READ

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Categories

Category